UW–Madison School of Medicine and Public Health: Intends to be the first in the United States to install innovative cancer treatment

MADISON, Wis. – The University of Wisconsin–Madison and TAE Life Sciences, a biotechnology company specializing in targeted radiation therapy for cancer care, have signed a memorandum of understanding, or MOU, announcing the intention to launch the first accelerator-based boron neutron capture therapy center in the United States. As part of this collaboration, the University of Wisc...